Search PDMR transactions

Notifier
Name of person with notification obligation
Quantass ApS
Reason for notification
Closely associated
Yes
Person discharging managerial responsibilities
Jeppe Oevlesen
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
SynAct Pharma AB
Issuer´s LEI code
549300RRYIEFEQ72N546
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share SynAct Pharma SE0008241491 Acquisition 18,500 Quantity 16.04426 SEK 19/06/2025 Outside a trading venue
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
SynAct Pharma SE0008241491 Acquisition 19/06/2025 Outside a trading venue 18,500 (Quantity) 16.04426 SEK
Total: 18,500
<< Back